Piper Sandler Sticks to Its Buy Rating for Moderna (MRNA)
In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Moderna (MRNA – Research Report), with a price target ...
Piper Sandler Remains a Hold on The Hershey Company (HSY)
Piper Sandler analyst Michael Lavery maintained a Hold rating on The Hershey Company (HSY – Research Report) today and set a price target of ...
Hosted on MSN16d
Goldman Sachs Downgrades Piper Sandler Companies (PIPR)
Fintel reports that on January 6, 2025, Goldman Sachs downgraded their outlook for Piper Sandler Companies (NYSE:PIPR) from Buy to Neutral. Analyst Price Forecast Suggests 25.14% Upside As of December ...